Incyte plans a transformational 2025 with four potential drug launches, pivotal trial readouts, and significant pipeline milestones targeting billion-dollar markets.

Therapy for atopic dermatitis is multi-faceted and encompasses ... so foams and lotions are preferred. Sometimes in severe disease, occlusive dressings may be employed. Occlusive dressings have ...

Clarivate Plc  a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watchtm report, a trusted guide to the therapies poised to redefine ...

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...

Some other medicines that are slated to become blockbusters in the near future include GSK’s vaccine candidate GSK-3536819 ...

Secukinumab delivers sustained efficacy and quality of life improvements in pediatric generalized pustular psoriasis (GPP).

Human metapneumovirus (HMPV) is a significant threat to infants, especially in colder months. Without a vaccine, it results in high hospital admissions and death rates in low-income countries.

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Four out of 10 children and adolescents with severe asthma also experienced high levels of fatigue, with poorer ...

Programme diaries were completed by 136 British children between August 2011 and March 2012. Subjects were evenly split as Caucasian and non-Caucasian and all parents spoke adequate English. One ...